January 2, 2019
BioLineRx to Present at the 2019 Biotech Showcase
December 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
December 6, 2018
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York
November 20, 2018
BioLineRx Announces Receipt of FDA Biological Product Designation for Novel Cancer Immunotherapy Candidate AGI-134